All Articles

HDI Global's appointment of Dan Feige isn't just a new hire; it's a strategic shot across the bow in the competitive US specialty insurance market.

The Object Management Group is standardizing Rust with its IDL4 framework, a move set to accelerate the language's adoption in critical enterprise systems.

For 11 years, CBTS has made CRN's elite list. We unpack how their full-stack strategy and focus on AI are redefining resilience for modern enterprises.

Ottawa is set to unveil a new law for First Nations water, but after decades of broken promises, will this legislation finally deliver or just be another drop in the bucket?

Highwire appoints veteran CFO Kelly Losko, a move that caps a period of intense growth, including a major acquisition and the launch of its proprietary AI platform.

After a $40 billion market collapse, venture capital is back with a new playbook. Anterra Capital’s new fund signals a shift from hype to real-world AI.

In Pensacola, historic homes are more than architecture; they're a story. But who gets to tell that story, and what happens when heritage meets marketing?

The financial giant extends its massive Security and Resiliency Initiative north, targeting defense, energy, and supply chains to bolster regional stability.

A new national awards program from She and Success Business Magazine seeks to elevate Canadian women entrepreneurs, addressing a critical need for recognition.

Pacer ETFs slashes fees and expands its Swan SOS series, intensifying competition in the $92 billion buffer ETF market for risk-conscious investors.

The retailer's second annual Pride Vinyl Collection is more than a seasonal campaign; it's a strategic fusion of music, cause marketing, and retail innovation.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

From luxury jewelry to aerospace alloys, the machinery behind precious metals is evolving. A Chinese tech company is now leading a global charge.

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

With a $50M seed round, Radical Numerics aims to build general biological intelligence, walking a fine line between curing disease and creating bioweapons.

BVI's new European training hub isn't just a facility; it's a response to a critical skills gap in medicine, revealing how industry is shaping our trust in healthcare.

1Password's strategic purchase of Apono aims to solve the identity crisis of the AI era, offering a unified platform for human and machine access.

A new precision drug, ART5803, is offering hope for a devastating brain disorder. Arialys Therapeutics is fast-tracking its development with key clinical trials.

A landmark study proves drones can safely transport human kidneys, a breakthrough that could slash wait times and save lives. But can we clear the regulatory hurdles?

As mid-year burnout and remote work disconnection threaten productivity, a new model emerges that replaces passive perks with high-tech, high-impact experiences.